The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone increases bone resorption in women with type 2 diabetes: a randomized, controlled trial (Q43114233)

From Wikidata
Jump to navigation Jump to search
scientific article published on 31 March 2010
edit
Language Label Description Also known as
English
The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone increases bone resorption in women with type 2 diabetes: a randomized, controlled trial
scientific article published on 31 March 2010

    Statements

    The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone increases bone resorption in women with type 2 diabetes: a randomized, controlled trial (English)
    Ugis Gruntmanis
    Steve Fordan
    Hans K Ghayee
    Shuaib M Abdullah
    Raphael See
    31 March 2010
    343-349

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit